SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F254147BBF05FAC5A2858A36B5A5496CFE51AA42F163420C38C9AC66B5792028EBA3026BE9F57BCA5D6B2D8BAEA8683F>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F254147BBF05FAC5A2858A36B5A5496CFE51AA42F163420C38C9AC66B5792028EBA3026BE9F57BCA5D6B2D8BAEA8683F
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F254147BBF05FAC5A2858A36B5A5496CFE51AA42F163420C38C9AC66B5792028EBA3026BE9F57BCA5D6B2D8BAEA8683F
http://www.w3.org/2000/01/rdf-schema#comment
"Taken together our data demonstrated that miR-429 might function as an antimetastatic miRNA to regulate HCC metastasis by directly targeting CRKL via modulating Raf/MEK/ERK-epithelial mesenchymal transition pathway."
xsd:string
http://purl.uniprot.org/uniprot/#_37AC94350290F8D22C443FC2D29FD082A2D5DBAF2DE5E782915C872E388FCC06E007952A29C113E57EBA9E88CF84FBF6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F254147BBF05FAC5A2858A36B5A5496CFE51AA42F163420C38C9AC66B5792028EBA3026BE9F57BCA5D6B2D8BAEA8683F
http://purl.uniprot.org/uniprot/L8E7R7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F254147BBF05FAC5A2858A36B5A5496CFE51AA42F163420C38C9AC66B5792028EBA3026BE9F57BCA5D6B2D8BAEA8683F
http://purl.uniprot.org/uniprot/#_L8E7R7-mappedCitation-29403024
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F254147BBF05FAC5A2858A36B5A5496CFE51AA42F163420C38C9AC66B5792028EBA3026BE9F57BCA5D6B2D8BAEA8683F